Showing results (131-140 of 191) with videos related to

Sort By:
Pageof 20
Journal of Leukocyte Biology|November 1, 1994
Neopterin production by HIV-1-infected mononuclear phagocytesC S Dukes, T J Matthews, E D Rivadeneira, et al.
Blood|October 1, 1989
Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicinK E Nichols, S R Chitneni, J O Moore, et al.
The Journal of Clinical Investigation|January 1, 1987
Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria cloneD V Devine, W L Gluck, W F Rosse, et al.
The Journal of Infectious Diseases|July 1, 1994
Human immunodeficiency virus (HIV)-infected human blood monocytes and peritoneal macrophages have reduced anticryptococcal activity whereas HIV-infected alveolar macrophages retain normal activityM L Cameron, D L Granger, T J Matthews, et al.
Osteoarthritis and Cartilage|April 24, 2007
Interleukin-1 and tumor necrosis factor alpha inhibit repair of the porcine meniscus in vitroA Hennerbichler, F T Moutos, D Hennerbichler, et al.
Blood|April 1, 1988
Cooperative effect of tumor necrosis factor and gamma-interferon on chemotactic peptide receptor expression and stimulus-induced actin polymerization in HL-60 cellsK M Rao, M A Misukonis, H J Cohen, et al.
Science (New York, N.Y.)|July 15, 1977
Macrophage tumor killing: influence of the local environmentJ B Hibbs, R R Taintor, H A Chapman, et al.
Blood|February 1, 1987
Antibodies to granulocyte precursors in selective myeloid hypoplasia and other suspected autoimmune neutropenias: use of HL-60 cells as targetsM S Currie, J B Weinberg, P K Rustagi, et al.
Journal of General Internal Medicine|February 1, 1995
A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: impact on glycemic control and health-related quality of lifeM Weinberger, M S Kirkman, G P Samsa, et al.
Arthritis and Rheumatism|December 31, 1998
Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2)D J Perkins, E W St Clair, M A Misukonis, et al.
Pageof 20